MBCL-36. HOW TO INCREASE SURVIVAL IN 7 TO 10% OF PATIENTS WITH AVERAGE-RISK MEDULLOBLASTOMA WITHOUT NEW THERAPIES: EARLY PROSPECTIVE NEURORADIOLOGY SCREENING EXPERIENCE FROM THE CHILDREN’S ONCOLOGY GROUP

BACKGROUND: Previous Children’s Oncology Group (COG) average-risk medulloblastoma studies retrospectively identified that 7 to 10% of patients were wrongly staged; either due to the presence of unequivocal residual disease greater than 1.5cm(2) or metastatic disease. Notably, these patients had an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gottardo, Nicholas, Leary, Sarah, Kang, Guolian, Gossett, Jeffrey, Fouladi, Maryam, Kessel, Sandy, Sabin, Noah, Jaju, Alok, Harreld, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715223/
http://dx.doi.org/10.1093/neuonc/noaa222.512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715223/
http://dx.doi.org/10.1093/neuonc/noaa222.512

Ejemplares similares